Natural Alternatives Int.

Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It operates through Private-Label Contract Manufacturing and Royalty, Licensing, and Raw Material Sales segments. The Private-Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Royalty, Licensing, and Raw Material Sales segment is associated with the sale and license of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. It operates through the Private-Label Contract Manufacturing, and Patent and Trademark Licensing segments. The Private-Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment is involved in direct raw material sales and royalty income from license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

CARLSBAD, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) today announced the expected May 2024 reopening of its state-of-the-art high-volume powder blending and packaging facility located in Carlsbad, CA, following a 7-month closure.

Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs

CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), today announced its expansion in Brazil with Barentz, creating an exclusive distribution channel for CarnoSyn® beta-alanine throughout the entire Brazilian dietary supplements' market.

CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine

CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $3.1 million, or $0.52 per diluted share, on net sales of $25.2 million for the second quarter of fiscal year 2024 compared to net income of $1.8 million, or $0.31 per diluted share, in the second quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results

CARLSBAD, Calif. , Nov. 9, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.7 million, or $0.12 per diluted share, on net sales of $34.0 million for the first quarter of fiscal year 2024 compared to net income of $1.1 million, or $0.18 per diluted share, in the first quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2024 Q1 Results

NEW YORK , Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Natural Alternatives International, Inc. ("NAI" or the "Company") (NASDAQ: NAII).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Natural Alternatives International, Inc. - NAII

NEW YORK , Sept. 21, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Natural Alternatives International, Inc. (NASDAQ: NAII) resulting from allegations that Natural Alternatives International may have issued materially misleading business information to the investing public.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Natural Alternatives International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - NAII

CARLSBAD, Calif. , Sept. 21, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $2.0 million, or $0.35 per diluted share, on net sales of $35.9 million for the fourth quarter of fiscal year 2023 compared to net income of $3.1 million, or $0.52 per diluted share, in the fourth quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2023 Q4 and YTD Results

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Natural Alternatives International, Inc. (NASDAQ: NAII) resulting from allegations that Natural Alternatives International may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Natural Alternatives International securities you may be entitled to compensation without paymen.

NAII INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Natural Alternatives International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation – NAII

CARLSBAD, Calif. , Aug. 16, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a temporary closure of its new facility in Carlsbad, California, opened earlier this year to expand NAI's production and add high-speed powder blending and packaging to its manufacturing capabilities, with an initial objective of handling current and estimated orders from one of its largest customers.

Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs

CARLSBAD, Calif. , July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth.

Natural Alternatives International Appoints New VP of Global Sales

CARLSBAD, Calif. , May 31, 2023 /PRNewswire/ -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to announce that SR CarnoSyn® sustained release beta-alanine has been selected as a finalist in this year's NutraIngredients-USA Awards in two categories: Ingredient of the Year: Healthy Aging and Ingredient of the Year: Cognitive Function.

SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023

Carlsbad, California Plant Allows Greater Supply Chain Flexibility and Supports Higher Volume of Production CARLSBAD, Calif. , May 24, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII) today announced the expansion of its global dietary supplement contract manufacturing network, providing the ability to better service existing customers, attract new customers, expand sales, and provide potential for channel and customer diversification.

Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California

CARLSBAD, Calif. , May 17, 2023 /PRNewswire/ -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), are proud to sponsor Dr. Guilherme G.

Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting

CARLSBAD, Calif. , May 15, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.4 million, or $0.41 per diluted share, on net sales of $32.7 million for the third quarter of fiscal year 2023 compared to net income of $2.5 million, or $0.41 per diluted share, in the third quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results

CARLSBAD, Calif. , Feb. 23, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, today announced that new research on the cognitive benefits of SR CarnoSyn® beta-alanine tablets, a patented sustained release delivery system owned by NAI, has been published in Nutrients.

NEWLY PUBLISHED STUDY SHOWS SR CARNOSYN® BETA-ALANINE IMPROVES COGNITIVE FUNCTION IN OLDER ADULTS

CARLSBAD, Calif. , Feb. 8, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.8 million, or $0.31 per diluted share, on net sales of $42.3 million for the second quarter of fiscal year 2023 compared to net income of $1.8 million, or $0.30 per diluted share, in the second quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2023 Q2 and YTD Results

NAII is a contract manufacturer of nutritional supplements, including its own brand of beta-alanine. The company has generated low and inconsistent profits, caused by a weak competitive position, coupled with high operating leverage.

Natural Alternatives: Low Moat And Trading At Cycle Peak Multiples

Epsilon Energy Ltd

FutureFuel

Mastech Digital

Mix Telematics

Marine Products

Tencent Music Entertainment Group 

With skyrocketing prices these days, we could all use a pick-me-up, which brings us to the best stocks under $15 to buy for 2023. For about the price of lunch in the current monetary paradigm, astute investors can instead choose to make their money work for them.

The 7 Best Stocks Under $15 to Buy Now

CARLSBAD, Calif. , Dec. 5, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $19.0 million.

Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase Plan

CARLSBAD, Calif. , Nov. 9, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.1 million, or $0.18 per diluted share, on net sales of $43.1 million for the first quarter of fiscal year 2023 compared to net income of $3.3 million, or $0.51 per diluted share, in the first quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2023 Q1 Results

2022 Q4: $52.5 million Net Sales (+18%), $3.1 million Net Income, and $0.52 Diluted EPS CARLSBAD, Calif. , Sept. 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.1 million, or $0.52 per diluted share, on net sales of $52.5 million for the fourth quarter of fiscal year 2022 compared to net income of $3.0 million, or $0.47 per diluted share, in the fourth quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2022 Q4 and YTD Results

2022 Q3:  Net Income Increased 30.7% and Diluted EPS Increased 36.7% Q4 Fiscal 2022 Outlook:  18% - 21% Net Sales Increase CARLSBAD, Calif. , May 13, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $2.5 million, or $0.41 per diluted share, on net sales of $42.4 million for the third quarter of fiscal year 2022 compared to net income of $1.9 million, or $0.30 per diluted share, in the third quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2022 Q3 and YTD Results

CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands.

NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

CARLSBAD, Calif., Feb. 9, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.8 million, or $0.30 per diluted share, on net sales of $37.7 million for the second quarter of fiscal year 2022 compared to net income of $3.6 million, or $0.57 per diluted share, in the second quarter of the prior fiscal year.

Natural Alternatives International, Inc. Announces 2022 Q2 and YTD Results

CARLSBAD, Calif., Jan. 31, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Sherri Balzer has joined as Business Development Manager, Health & Wellness.

News for Natural Alternatives Int. Stock (NAII)